1 day ago
1
Maksim Labkouski
Which cancer drug developers are attractive takeover targets?
We asked Seeking Alpha analysts BioCGT Investor, ALLKA Research and Zach Hartman for their picks.
BioCGT Investor: Cardiff Oncology (NASDAQ:CRDF), which is on the verge of releasing Phase 2 clinical
English (US) ·